Xeris Biopharma Holdings, Inc. Nasdaq
Equities
XERS
US98422L1070
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+23.85% | 653B | |
+25.98% | 556B | |
-6.36% | 354B | |
+20.35% | 331B | |
+6.18% | 296B | |
+12.75% | 233B | |
+5.43% | 201B | |
-9.86% | 193B | |
-6.50% | 144B |
1st Jan change | Capi. | |
---|---|---|
+23.85% | 653B | |
+25.98% | 556B | |
-6.36% | 354B | |
+20.35% | 331B | |
+6.18% | 296B | |
+12.75% | 233B | |
+5.43% | 201B | |
-9.86% | 193B | |
-6.50% | 144B |